Extracorporeal Membrane Oxygenation
74
15
18
27
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.7%
2 terminated out of 74 trials
93.1%
+6.6% vs benchmark
5%
4 trials in Phase 3/4
7%
2 of 27 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 27 completed trials
Clinical Trials (74)
ECMO Treatment of Children in China in the Past 10 Years
Risk Factors of Bleeding Under Veno Arterial Membrane Oxygenation
Impact of the Implementation of a Referral Veno-venous Extracorporeal Membrane Oxygenation Centre on Mortality
Predictors for Survival and Good Neurological Outcome in E-CPR and Non CPR Treated Patients
ARDS in Children and ECMO Initiation Strategies Impact on Neurodevelopment (ASCEND)
ON-SCENE Initiation of Extracorporeal CardioPulmonary Resuscitation During Refractory Out-of-Hospital Cardiac Arrest
Trial of Indication-Based Transfusion of Red Blood Cells in ECMO
Hydrogen's Feasibility and Safety as a Therapy in ECPR
Effect of Transpulmonary MP on Prognosis of Patients With Severe ARDS Treated With VV-ECMO
Evaluation of Membrane Lung Function in High-altitude Regions
Biomarkers of Brain Injury in Critically-Ill Children on Extracorporeal Membrane Oxygenation
Reduced Anticoagulation Targets in ECLS (RATE)
Low Frequency, Ultra-low Tidal Volume Ventilation in Patients With ARDS and ECMO
HRQOL of Life After ECMO Due to COVID-19.
Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO
Efficacy and Safety of Synchronized Cardiac Support in Cardiogenic Shock Patients
Effect of Reduced Vasopressors on Mortality in ECMO-supported Cardiogenic Shock Patients
The OSIRIS ECPR Trial
Reduction of Blood Recirculation in Veno-Venous ECMO
Normoxemic Versus Hyperoxemic Extracorporeal Oxygenation in Patients Supported by Veino-arterial ECMO for Cardiogenic Shock